Mucinous cystadenocarcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mucinous cystadenocarcinoma}} | {{Mucinous cystadenocarcinoma}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}}{{Qurrat}}, {{Ammu}} | ||
==Overview== | ==Overview== | ||
The main mode of treatment of mucinous cystadenocarcinoma is [[chemotherapy]] and [[radiation]]. | The main mode of treatment of [[mucinous cystadenocarcinoma]] is [[chemotherapy]] and [[radiation]]. | ||
==Medical Therapy== | ==Medical Therapy== | ||
* | * Primary modality of treatment of [[mucinous cystadenocarcinoma]] is [[surgical resection]] followed by [[chemotherapy]] and [[radiation]].<ref>Ovary Epithelial tumors. Atlasgeneticsoncology (2016).http://atlasgeneticsoncology.org/Tumors/OvaryEpithTumID5230.html Accessed on February 29, 2016</ref> | ||
* [[Adjuvant therapy]] after [[resection]] of the [[tumor]] with positive margins and involved [[Lymph node|lymph nodes]] has shown to improves [[Survival analysis|survival]]. <ref name="pmid26587698">{{cite journal |vauthors=McMillan MT, Lewis RS, Drebin JA, Teitelbaum UR, Lee MK, Roses RE, Fraker DL, Vollmer CM |title=The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN) |journal=Cancer |volume=122 |issue=4 |pages=521–33 |date=February 2016 |pmid=26587698 |doi=10.1002/cncr.29803 |url=}}</ref> | |||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 18:45, 19 April 2019
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma medical therapy |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Ammu Susheela, M.D. [3]
Overview
The main mode of treatment of mucinous cystadenocarcinoma is chemotherapy and radiation.
Medical Therapy
- Primary modality of treatment of mucinous cystadenocarcinoma is surgical resection followed by chemotherapy and radiation.[1]
- Adjuvant therapy after resection of the tumor with positive margins and involved lymph nodes has shown to improves survival. [2]
Reference
- ↑ Ovary Epithelial tumors. Atlasgeneticsoncology (2016).http://atlasgeneticsoncology.org/Tumors/OvaryEpithTumID5230.html Accessed on February 29, 2016
- ↑ McMillan MT, Lewis RS, Drebin JA, Teitelbaum UR, Lee MK, Roses RE, Fraker DL, Vollmer CM (February 2016). "The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)". Cancer. 122 (4): 521–33. doi:10.1002/cncr.29803. PMID 26587698.